BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27437087)

  • 1. Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes.
    Ryu CS; Oh SJ; Oh JM; Lee JY; Lee SY; Chae JW; Kwon KI; Kim SK
    Toxicol Res; 2016 Jul; 32(3):207-13. PubMed ID: 27437087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
    Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
    Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
    He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
    Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang C; Li Y; Yin C; Zheng J; Liu G
    Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of carteolol by cDNA-expressed human cytochrome P450.
    Kudo S; Uchida M; Odomi M
    Eur J Clin Pharmacol; 1997; 52(6):479-85. PubMed ID: 9342584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
    Usmani KA; Karoly ED; Hodgson E; Rose RL
    Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Inhibitory Effects of Cynaroside on Human Liver Cytochrome P450 Enzymes.
    Wang L; Ma X; Wang J; Li C
    Pharmacology; 2019; 104(5-6):296-302. PubMed ID: 31587003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes.
    Endo T; Ban M; Hirata K; Yamamoto A; Hara Y; Momose Y
    Drug Metab Dispos; 2007 Mar; 35(3):476-83. PubMed ID: 17178767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
    Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
    Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
    AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.
    Liu L; Sun S; Rui H; Li X
    Pharm Biol; 2017 Dec; 55(1):1868-1874. PubMed ID: 28614988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
    Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Li J; Wen H; Gao Z
    Xenobiotica; 2020 Feb; 50(2):231-236. PubMed ID: 31020909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
    Yamazaki H; Shimada T
    Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes.
    Wu Y; Qiao A; Lin S; Chen L
    BMC Complement Med Ther; 2022 Feb; 22(1):46. PubMed ID: 35180866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
    Fasinu PS; Bouic PJ; Rosenkranz B
    Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.